Concepedia

Malick M. Gibani

MM

35

Publications

4K

Citations

24

H-Index

2015

Active since

Affiliations

University of Oxford(Current)

Oxford BioMedica (United Kingdom)

Imperial College London

National Institute for Health Research

University of Liverpool

Malick M. Gibani is an author at University of Oxford specializing in medicine, immunology, and infection control.

ORCID

Top concepts

Publications per year

2015–2024

35

Publications

35

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Katie Ewer, Tommy Rampling, Navin Venkatraman et al. · New England Journal of Medicine · 2015 · 353 citations · Full text

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

Iain Milligan, Malick M. Gibani, Richard P. Sewell et al. · JAMA · 2016 · 321 citations

Rows per page

1–5 of 35